COPD Care Transition Programs for Chronic Obstructive Pulmonary Disease
(REVISITS Trial)
Trial Summary
Do I need to stop taking my current medications for this trial?
The trial protocol does not specify whether participants need to stop taking their current medications.
What data supports the idea that COPD Care Transition Programs for Chronic Obstructive Pulmonary Disease is an effective treatment?
The available research shows that COPD Care Transition Programs can effectively reduce hospital readmissions for patients with chronic obstructive pulmonary disease. For example, the BREATHE study developed a program to help patients and their families manage COPD at home, which is crucial for preventing future hospital visits. Another study found that using a transition care bundle led to fewer hospital readmissions compared to usual care. Additionally, these programs can improve the quality of life for patients by providing comprehensive care that addresses not only the respiratory issues but also other related health problems. This approach is more effective than just using medication alone, as it includes education, personalized treatment plans, and support for both patients and their families.12345
What safety data exists for COPD care transition programs?
The safety data for COPD care transition programs, including discharge care bundles, suggest that these interventions can improve patient outcomes, such as reducing hospital readmissions and mortality rates. Studies like the BREATHE study and systematic reviews indicate that these programs are effective in managing COPD post-discharge, although there is a need for more research to standardize the interventions and address care gaps.25678
Is the COPD Transitions of Care Intervention Bundle a promising treatment for COPD?
Yes, the COPD Transitions of Care Intervention Bundle is a promising treatment. It helps reduce hospital readmissions, improves patient health, and can lower healthcare costs. It focuses on better care coordination and patient education, which empowers patients and their families to manage COPD more effectively at home.12345
What is the purpose of this trial?
This type II hybrid effectiveness-implementation trial will concurrently study the comparative effectiveness of virtual vs. in-person COPD care transition programs implemented via virtual mentored implementation approaches with and without co-design methods.The investigators will enroll up to 24 randomized sites (with a goal minimum of 16 sites) to:* Deliver the COPD programs implemented via mentored support in collaboration with SHM Center for Quality Improvement.* Compare the effectiveness and penetration of virtual versus in-person COPD care transition programs implemented along with mentoring support with or without co-design.The investigators aim to determine which combined approach(es) is/are the most effective at implementing evidence-based COPD program interventions and decreasing COPD acute care revisits with the greatest overall impact and sustainability.
Research Team
Valerie G Press, MD, MPH
Principal Investigator
University of Chicago
Eligibility Criteria
This trial is for US hospital sites, not individuals. It's designed to compare the effectiveness of virtual versus in-person care transition programs for patients with Chronic Obstructive Pulmonary Disease (COPD).Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Implementation of COPD care transition programs via virtual or in-person delivery with virtual mentoring over a one-year period
Follow-up
Participants are monitored for sustainability of intervention and implementation outcomes at 6, 12, 18, and 24 months post-implementation
Treatment Details
Interventions
- COPD Transitions of Care Intervention Bundle: In-Person Interventions
- COPD Transitions of Care Intervention Bundle: Virtual Interventions
COPD Transitions of Care Intervention Bundle: In-Person Interventions is already approved in United States, European Union for the following indications:
- Chronic Obstructive Pulmonary Disease
- Chronic Obstructive Pulmonary Disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
The Hospital Medicine Reengineering Network (HOMERuN)
Collaborator
Onda Collective
Collaborator
COPD Foundation
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Society of Hospital Medicine
Collaborator